Preview

Current Pediatrics

Advanced search

EFFECTIVENESS AND SAFETY OF PIMECROLIMUS IN TREATMENT OF ATOPIC DERMATITIS IN CHILDREN AND ADOLESCENTS

Abstract

The results of treatment of 57 patients with atopic dermatitis (ATD) in age 7–18 years old with elidel cream are described. Cream was drifted on facial skin 2 times daily. Apparent effect was marked on 7–14 day. There was no any case of serious adverse events. Thus, taking to account safety and effectiveness profile, pimecrolimus can be used as a medication of first line of therapy in treatment of ATD, while lesion is located on sensitive sectors of skin.
Key words: children, atopic dermatitis, pimecrolimus.

About the Authors

K.N. Monakhov
I.P. Pavlov St.9Petersburg Medical University
Russian Federation


S.A. Ochelenko
I.P. Pavlov St.9Petersburg Medical University
Russian Federation


References

1. Ashcroft D., Dimmock P., Garside R. et al. Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta–analysis of randomised controlled trials. BMJ. 2005; 330 (7490): 516.

2. Williams H., Robertson C., Stewart A. et al. Worldwide variations in the prevalence of symptoms of atopic eczema in the international study of asthma and allergies in childhood. J. Allergy Clin. Immunol. 1999; 103 (1): 125–138.

3. Laughter D., Istvan J., Tofte S. et al. The prevalence of atopic dermatitis in Oregon schoolchildren. J. Am. Acad. Dermatol. 2000; 43 (4): 649–655.

4. Jennifer D., Peterson M., Lawrence S. et al. A comprehensive management guide for atopic dermatitis. Dermatol. Nurs. 2006; 18 (6): 531–542.

5. Sulzberger M., Witten V. The effect of topically applied compound F in selected dermatoses. J. Invest. Dermatol. 1952; 19 (2): 101–102.

6. Hengge U., Ruzicka T., Schwartz R. et al. Adverse effects of topical glucocorticosteroids. J. Am. Acad. Dermatol. 2006; 54 (1): 1–15.

7. Giusti F., Martella A., Bertoni L. et al. Skin barrier, hydration, and PH of the skin of infants under 2 years of age. Pediatr. Derm. 2001; 18 (2): 93–96.

8. Walsh P., Aeling G., Huff L. et al. Hypotalamus pituitary adrenal axis suppression by superpotent steroids. J. Am. Acad. Dermatol. 1993; 29 (3): 501–503.

9. Корсунская И.М., Дворянкова Е.В. Новые препараты в местной терапии атопического дерматита. Consilium Medicum. 2004; 6 (3): 14–17.

10. Stuetz A., Grassberg M., Meingasser J. Pimecrolimus (Elidel, SDZ ASM 981) – preclinical pharmacologic profile and skin selectivity. Semin. Cutan. Med. Surg. 2001; 20 (4): 233–241.

11. Kalthoff F., Meingassner J., Chung J. et al. Pimecrolimus and tacrolimus differ in their inhibition of lymphocyte activation during the sensitization phase of contact hypersensitivity. J. Dermatol. Sci. 2006; 43 (2): 117–126.

12. Reuters Health Information 2006. Pimecrolimus cream provides fast relief of pruritus. Allergy. 2006; 61: 375–381.


Review

For citations:


Monakhov K., Ochelenko S. EFFECTIVENESS AND SAFETY OF PIMECROLIMUS IN TREATMENT OF ATOPIC DERMATITIS IN CHILDREN AND ADOLESCENTS. Current Pediatrics. 2008;7(6):141-144.

Views: 608


ISSN 1682-5527 (Print)
ISSN 1682-5535 (Online)